Skip to main content
. 2014 May 26;8(2):509–514. doi: 10.3892/etm.2014.1733

Table I.

Baseline characteristics among the three groups.

Characteristic Pre-ERCP som (n=81) Post-ERCP som (n=126) Control (n=97) P-value
Age (years; mean ± SD) 59.31±14.61 56.06±14.38 56.23±15.94 0.262
Gender (female/male) 41/40 58/68 52/45 0.519
Indications [n (%)]
 Biliary ductal stones 59 (72.8) 92 (73.0) 66 (68.0) 0.684
 Recent acute pancreatitis 9 (11.1) 8 (6.3) 7 (7.2) 0.438
 Malignancy 5 (6.2) 12 (9.5) 11 (11.3) 0.503
 Others 8 (9.9) 14 (11.1) 13 (13.4 ) 0.764
SOD [n (%)] 15 (18.5) 27 (21.4) 14 (14.4) 0.414
Difficult cannulationa [n (%)] 16 (19.8) 17 (13.5) 12 (12.4) 0.349
Precut sphincterotomy [n (%)] 14 (17.3) 12 (9.5) 11 (11.3) 0.221
Pancreatic duct injection [n (%)] 26 (32.1) 44 (34.9) 34 (35.1) 0.906
Biliary sphincterotomy [n (%)] 66 (81.5) 100 (79.4) 76 (78.4) 0.888
Stone extraction [n (%)] 59 (72.8) 91 (72.2) 65 (67.0) 0.635
Drain insertionb [n (%)] 10 (12.3) 18 (14.3) 21 (21.6) 0.206
Pancreatic duct stenting [n (%)] 9 (11.1) 10 (7.9) 6 (6.2) 0.501
a

Difficult cannulation (≥3 cannulation attempts);

b

drain insertion includes biliary stenting and nasobiliary drainage.

SOD, sphincter of Oddi dysfunction; pre-ERCP som, pre-endoscopic retrograde cholangiopancreatography somatostatin administration; post-ERCP som, post-endoscopic retrograde cholangiopancreatography somatostatin administration.